Champalimaud Foundation
Marta Estrada is a seasoned researcher specializing in cancer biology and personalized medicine, currently leading a phase IV clinical trial on the zAvatar-test for relapsed ovarian cancer and metastatic breast cancer at the Champalimaud Foundation. With a strong background in the development of innovative cancer treatments, Marta has contributed to various projects aimed at enhancing patient-specific therapy models, including roles as co-PI on significant research initiatives for ovarian cancer avatars and AI-empowered analyses. Previous experience spans several research positions, including a PhD at Faculdade de Ciências e Tecnologia da Universidade NOVA de Lisboa and work at institutions such as iBET and EPFL, focusing on drug efficacy testing models and cancer cell cultures. Educational qualifications include a PhD in Biological Engineering and a Master's in Biotechnology, both from Universidade NOVA de Lisboa.
Champalimaud Foundation
The mission of the Champalimaud Foundation is to develop programmes of advanced biomedical research and provide clinical care of excellence, with a focus on translating pioneering scientific discoveries into solutions which can improve the quality of life of individuals around the world. This is done with independence, rigour, dedication, creativity and with a commitment to meet the highest ethical and scientific standards. By its actions the Foundation strives to be a world leader in scientific and technological innovation with the ultimate objective of preventing, diagnosing and treating disease. In so doing, the Foundation is guided by the constant challenge of finding new solutions to humanity’s most pressing health problems.